Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.87
$0.01991.08%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 317.48% | 487.50% | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 317.48% | 487.50% | -- | -- | -- |
Cost of Revenue | 1,025.00% | 715.38% | -- | -- | -- |
Gross Profit | 102.53% | 377.78% | -- | -- | -- |
SG&A Expenses | -15.40% | -7.20% | 4.89% | 0.35% | 38.11% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -15.80% | -8.87% | -5.13% | 22.24% | 49.90% |
Operating Income | 19.62% | 11.16% | 7.80% | -19.88% | -48.20% |
Income Before Tax | 13.56% | 4.64% | 1.07% | -19.14% | -47.29% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 13.56% | 4.64% | 1.07% | -19.14% | -47.29% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 13.56% | 4.64% | 1.07% | -19.14% | -47.29% |
EBIT | 19.62% | 11.16% | 7.80% | -19.88% | -48.20% |
EBITDA | 19.46% | 10.95% | 7.54% | -20.34% | -48.90% |
EPS Basic | 22.22% | 15.72% | 14.48% | 2.35% | -22.47% |
Normalized Basic EPS | 26.69% | 19.26% | 17.24% | -1.42% | -24.81% |
EPS Diluted | 22.22% | 15.72% | 14.48% | 2.35% | -22.47% |
Normalized Diluted EPS | 26.69% | 19.26% | 17.24% | -1.42% | -24.81% |
Average Basic Shares Outstanding | 9.94% | 10.64% | 13.42% | 18.60% | 18.54% |
Average Diluted Shares Outstanding | 9.94% | 10.64% | 13.42% | 18.60% | 18.54% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |